{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:09Z","timestamp":1792794669677,"version":"4.5.0"},"reference-count":0,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,9,3]],"date-time":"2004-09-03T00:00:00Z","timestamp":1094169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The enzyme adenylosuccinate lyase (ADSL) intervenes twice in the biosynthesis of adenine nucleotides. ADSL deficiency is an inherited metabolic disease characterized by various degrees of psychomotor retardation and accumulation of dephosphorylated enzyme substrates 5\u2010amino\u20104\u2010imidazole\u2010<jats:italic>N<\/jats:italic>\u2010succinocarboxamide riboside (SAICAr) and succinyladenosine (SAdo) in body fluids. Severity of symptoms seems to correlate with residual activity of mutant enzyme and with SAdo\/SAICAr concentration ratio in cerebrospinal fluid. To better understand the pathogenetic mechanisms of the disease symptoms, studies of catalytic properties of mutant enzymes together with <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments utilizing SAICAr and SAdo must be performed. Such studies require availability of both ADSL substrates, 5\u2010amino\u20104\u2010imidazole\u2010<jats:italic>N<\/jats:italic>\u2010succinocarboxamide ribotide (SAICAR) and succinyladenosine 5\u2032\u2010monophosphate (SAMP) and their dephosphorylated products in sufficient amounts and purity. Except for SAMP, none of these compounds is commercially available and they must therefore be synthesized. SAICAR was prepared by recombinant human ADSL\u2010catalysed reaction of AICAR (5\u2010aminoimidazole\u20104\u2010carboxamide) with fumarate and isolated by thin\u2010layer chromatography. SAICAr and SAdo were prepared by calf intestine alkaline phosphatase\u2010catalysed dephosphorylation of SAICAR and SAMP and isolated on cation\u2010 and anion\u2010exchange resin columns. The procedures described are easily scalable and provide high yields of sufficiently pure products for use in experiments related to studies of pathogenetic mechanisms in ADSL deficiency.<\/jats:p>","DOI":"10.1007\/s10545-005-0493-z","type":"journal-article","created":{"date-parts":[[2005,5,17]],"date-time":"2005-05-17T12:50:32Z","timestamp":1116334232000},"page":"493-499","source":"Crossref","is-referenced-by-count":25,"title":["Preparation of 5\u2010amino\u20104\u2010imidazole\u2010<i>N<\/i>\u2010succinocarboxamide ribotide, 5\u2010amino\u20104\u2010imidazole\u2010<i>N<\/i>\u2010succinocarboxamide riboside and succinyladenosine, compounds usable in diagnosis and research of adenylosuccinate lyase deficiency"],"prefix":"10.1002","volume":"28","author":[{"given":"M.","family":"Zik\u00e1nov\u00e1","sequence":"first","affiliation":[{"name":"Center for Applied Genomics, Institute for Inherited Metabolic Disorders Charles University First School of Medicine  Prague Czech Republic"},{"name":"Institute for Inherited Metabolic Disorders  Ke Karlovu 2 Prague 2 128 08 Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Krijt","sequence":"additional","affiliation":[{"name":"Center for Applied Genomics, Institute for Inherited Metabolic Disorders Charles University First School of Medicine  Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hartmannov\u00e1","sequence":"additional","affiliation":[{"name":"Center for Applied Genomics, Institute for Inherited Metabolic Disorders Charles University First School of Medicine  Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kmoch","sequence":"additional","affiliation":[{"name":"Center for Applied Genomics, Institute for Inherited Metabolic Disorders Charles University First School of Medicine  Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,3]]},"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-005-0493-z","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-005-0493-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:22:23Z","timestamp":1694737343000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-005-0493-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,3]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1007\/s10545-005-0493-z"],"URL":"https:\/\/doi.org\/10.1007\/s10545-005-0493-z","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,3]]}}}